American Healthcare REIT
AHR
57.54
-0.07
-0.12%
American Healthcare REIT
US · AHR
#1336 by market cap
Listed 2024
57.54
-0.07
-0.12%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
Recent news
-
Company notice
American Healthcare REIT | 8-K: American Healthcare REIT (“AHR”) Announces Second Quarter 2025 Results; Increases Full Year 2025 GuidanceSEC · 2025/8/8
-
Company notice
American Healthcare REIT | 8-K: American Healthcare REIT (“AHR”) Announces Fourth Quarter 2024 and Full Year 2024 Results; Issues Full Year 2025 GuidanceSEC · 2025/2/28
-
UBS Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $71Market Newswire · 2026/11/11
-
Citi Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $67Market Newswire · 2026/11/10
-
BofA Securities Maintains American Healthcare REIT(AHR.US) With Buy Rating, Announces Target Price $74Market Newswire · 2026/11/13
-
Rating change
Barclays Maintains American Healthcare REIT(AHR.US) With Buy Rating, Cuts Target Price to $60Market Newswire · 2026/10/13
-
Rating change
Scotiabank Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $62Market Newswire · 2026/9/2
-
Rating change
Barclays Sticks to Their Buy Rating for American Healthcare REIT, Inc. (AHR)TipRanks · 2026/10/13
-
Company notice
American Healthcare REIT | 8-K: American Healthcare REIT (“AHR”) Announces Fourth Quarter 2025 and Full Year 2025 Results; Issues Full Year 2026 GuidanceSEC · 2026/2/27
-
Rating change
Barclays Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $66Market Newswire · 2026/8/31
-
Company notice
American Healthcare REIT | 8-K: American Healthcare REIT (“AHR”) Announces First Quarter 2025 Results; Increases Full Year 2025 GuidanceSEC · 2025/5/9
-
Company notice
American Healthcare REIT | 8-K: American Healthcare REIT (“AHR”) Announces Third Quarter 2025 Results; Increases Full Year 2025 GuidanceSEC · 2025/11/7
-
Scotiabank Maintains American Healthcare REIT(AHR.US) With Buy Rating, Maintains Target Price $62Market Newswire · 2026/11/6
-
Rating change
Barclays Remains a Buy on American Healthcare REIT, Inc. (AHR)TipRanks · 2026/8/31
-
Rating change
UBS Maintains American Healthcare REIT(AHR.US) With Buy Rating, Cuts Target Price to $62Market Newswire · 2026/10/13
-
Rating change
BMO Capital Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $65Market Newswire · 2026/10/2
-
Rating change
Raymond James Initiates American Healthcare REIT(AHR.US) With Buy Rating, Announces Target Price $62Market Newswire · 2026/10/13
-
KeyBanc Maintains American Healthcare REIT(AHR.US) With Buy RatingMarket Newswire · 2026/11/16
-
Rating change
RBC Capital Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $66Market Newswire · 2026/11/10
-
Rating change
BofA Securities Maintains American Healthcare REIT(AHR.US) With Buy RatingMarket Newswire · 2026/9/15
-
Rating change
KeyBanc Sticks to Their Buy Rating for American Healthcare REIT, Inc. (AHR)TipRanks · 2026/8/19
-
Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance Its Colon-Targeted AhR Agonist, AT177, for Ulcerative ColitisGlobeNewswire · 2026/10/16
-
Rating change
UBS Remains a Buy on American Healthcare REIT, Inc. (AHR)TipRanks · 2026/8/21
-
Rating change
KeyBanc Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $68Market Newswire · 2026/8/19
-
Rating change
UBS Maintains American Healthcare REIT(AHR.US) With Buy Rating, Maintains Target Price $63Market Newswire · 2026/8/21
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:01:32 · For reference only, not investment advice and not tailored to your situation.
American Healthcare REIT discussion 0 comments